Name Funds
holding
Growth Growth % Return since
31 Dec ‘24
101
10 +6 +150% 30.7%
102
10 +6 +150% 14.3%
103
10 +6 +150% 75.2%
KAPA
104
Kairos Pharma
KAPA
$13.7M
5 +3 +150% 56.8%
105
5 +3 +150% 6.27%
106
5 +3 +150% 2.83%
107
5 +3 +150% 41.2%
108
5 +3 +150% 97.8%
109
5 +3 +150% 1.83%
110
5 +3 +150% 22.2%
ITDF icon
111
iShares LifePath Target Date 2050 ETF
ITDF
$57.7M
5 +3 +150% 21.4%
112
5 +3 +150% 51.6%
113
5 +3 +150% 7.65%
114
5 +3 +150% 99.9%
115
5 +3 +150% 15.5%
116
5 +3 +150% 20.4%
117
5 +3 +150% 30.2%
118
5 +3 +150% 57.7%
119
5 +3 +150% 37.1%
120
5 +3 +150% 10.5%
121
5 +3 +150% 23.9%
122
5 +3 +150% 4.43%
123
5 +3 +150% 60.3%
124
22 +13 +144% 4.39%
125
17 +10 +143% 90.1%